BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18628995)

  • 1. Modulation of NKT cell development by B7-CD28 interaction: an expanding horizon for costimulation.
    Zheng X; Zhang H; Yin L; Wang CR; Liu Y; Zheng P
    PLoS One; 2008 Jul; 3(7):e2703. PubMed ID: 18628995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of thymic NKT cell development by the B7-CD28 costimulatory pathway.
    Williams JA; Lumsden JM; Yu X; Feigenbaum L; Zhang J; Steinberg SM; Hodes RJ
    J Immunol; 2008 Jul; 181(2):907-17. PubMed ID: 18606642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
    Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
    J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.
    Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L
    J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of NKT cell differentiation by tissue-specific microenvironments.
    Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
    J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7-CD28 interaction promotes proliferation and survival but suppresses differentiation of CD4-CD8- T cells in the thymus.
    Zheng X; Gao JX; Chang X; Wang Y; Liu Y; Wen J; Zhang H; Zhang J; Liu Y; Zheng P
    J Immunol; 2004 Aug; 173(4):2253-61. PubMed ID: 15294937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7/CD28 costimulation is critical in susceptibility to Pseudomonas aeruginosa corneal infection: a comparative study using monoclonal antibody blockade and CD28-deficient mice.
    Hazlett LD; McClellan S; Barrett R; Rudner X
    J Immunol; 2001 Jan; 166(2):1292-9. PubMed ID: 11145712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice.
    Heinly CS; Sempowski GD; Lee DM; Patel DD; McDermott PM; Scearce RM; Thompson CB; Haynes BF
    Int Immunol; 2001 Feb; 13(2):157-66. PubMed ID: 11157849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice.
    Wille U; Villegas EN; Craig L; Peach R; Hunter CA
    Infect Immun; 2002 Dec; 70(12):6940-7. PubMed ID: 12438373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice.
    Villegas EN; Wille U; Craig L; Linsley PS; Rennick DM; Peach R; Hunter CA
    Infect Immun; 2000 May; 68(5):2837-44. PubMed ID: 10768980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade.
    Girvin AM; Dal Canto MC; Rhee L; Salomon B; Sharpe A; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(1):136-43. PubMed ID: 10605004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand.
    Wu Y; Xu J; Shinde S; Grewal I; Henderson T; Flavell RA; Liu Y
    Curr Biol; 1995 Nov; 5(11):1303-11. PubMed ID: 8574588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response.
    Fuse S; Zhang W; Usherwood EJ
    J Immunol; 2008 Jan; 180(2):1148-57. PubMed ID: 18178855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.
    Pellicci DG; Hammond KJ; Uldrich AP; Baxter AG; Smyth MJ; Godfrey DI
    J Exp Med; 2002 Apr; 195(7):835-44. PubMed ID: 11927628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD7 and CD28 are required for murine CD4+CD25+ regulatory T cell homeostasis and prevention of thyroiditis.
    Sempowski GD; Cross SJ; Heinly CS; Scearce RM; Haynes BF
    J Immunol; 2004 Jan; 172(2):787-94. PubMed ID: 14707048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.
    Salomon B; Lenschow DJ; Rhee L; Ashourian N; Singh B; Sharpe A; Bluestone JA
    Immunity; 2000 Apr; 12(4):431-40. PubMed ID: 10795741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.
    Guo Y; Wu Y; Zhao M; Kong XP; Liu Y
    J Exp Med; 1995 Apr; 181(4):1345-55. PubMed ID: 7535334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.